Minovia Therapeutics
PrivateLast Round
M&A
Jan 30, 2026
Total Funding Raised
$36M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Minovia Therapeutics is a clinical-stage biotechnology company that develops novel therapies to treat mitochondrial diseases and combat age-related decline using its proprietary Mitochondrial Augmentation Therapy (MAT) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Minovia Therapeutics Comparables
Compare Minovia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PAEAN Biotechnology | 80% | |
| cellvie | 78% | |
| Taiwan Mitochondrion Applied Technology Co., Ltd. | 77% | |
Minovia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Jan 30, 2026 | ||||
| Grant | Aug 27, 2025 | ||||
| Corporate Funding | Jul 30, 2021 | ||||
| Series A | Dec 1, 2018 |
Minovia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Launch One Acquisition Corp. | M&A |
| Countdown For A Cure Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 12, 3x the trailing average.
- Jul 20, 2026
Open roles increased from 0 to 12, representing 50% of headcount.
Minovia Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Minovia Therapeutics's valuation, stock price, and market status.